文献速递乳房整形与再造

生物补片与合成补片在放疗后植入物乳房重建中的系统评价与荟萃分析

Biologic versus synthetic meshes in irradiated implant-based breast reconstruction: A systematic review and meta-analysis.
PubMed 文献 · J Plast Reconstr Aesthet Surg · 2026-07-03

该系统评价与荟萃分析纳入51项研究,比较放疗患者植入物乳房重建中生物补片与合成补片的并发症结局。生物补片总并发症率为33%(95%CI 25-41%),合成补片为30%(95%CI 13-56%),差异无统计学意义。胸肌下植入与植入物丢失和包膜挛缩风险升高相关,术前放疗与植入物丢失风险升高相关,补片类型对多数并发症无显著影响。

要点

  • 放疗后植入物乳房重建中,生物补片与合成补片的总并发症率无显著差异。
  • 胸肌下植入较胸肌前植入显著增加植入物丢失和包膜挛缩风险。
  • 术前放疗与植入物丢失风险升高相关,补片选择应结合临床与经济因素个体化。

核心结论

  • 在放疗患者植入物乳房重建中,生物补片与合成补片的总并发症率无显著差异。
  • 补片类型对包膜挛缩、植入物丢失、血清肿或坏死无显著影响。
  • 植入物放置层次和放疗时机是并发症的预测因素,支持基于临床和经济考虑的个体化补片选择。

研究设计与样本

  • 纳入51项报告放疗患者植入物乳房重建使用生物或合成补片并提供并发症结局数据的研究。
  • 采用单变量和多变量随机效应荟萃分析,多变量模型调整补片类型、植入物放置层次(胸肌下 vs. 胸肌前)和放疗时机(术前 vs. 术后)。

主要发现

  • 生物补片总并发症率为33%(95%CI 25-41%,p<0.001),合成补片为30%(95%CI 13-56%,p=0.347),两者无显著差异。
  • 胸肌下放置较胸肌前放置与植入物丢失风险升高显著相关(OR=2.32,95%CI 1.24-4.33,p=0.0086)。
  • 胸肌下放置较胸肌前放置与包膜挛缩风险升高显著相关(OR=2.91,95%CI 1.22-6.95,p=0.0165)。
  • 术前放疗与植入物丢失风险升高相关(OR=1.89,95%CI 1.21-2.94,p=0.0051)。
  • 补片类型对包膜挛缩、植入物丢失、血清肿或坏死的发生率无显著影响。

临床怎么用

  • 放疗后植入物乳房重建中,生物补片与合成补片临床结局相当,补片选择可结合临床与经济因素个体化。
  • 胸肌前放置可能降低植入物丢失和包膜挛缩风险,但需结合患者具体情况。
  • 术前放疗患者植入物丢失风险较高,应加强围手术期评估与告知。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Implant-based breast reconstruction (IBBR) is widely used after mastectomy and often involves incorporation of biologic or synthetic meshes. In patients receiving radiation therapy, complication rates can be up to twice as high in IBBR; however, the comparative safety of mesh types in this setting remains unclear. This meta-analysis aimed to evaluate outcomes of biologic versus synthetic mesh use in irradiated patients who underwent IBBR. METHODS: We searched the MEDLINE, Embase, and CENTRAL databases through November 14, 2024. Studies were included if they reported on irradiated patients undergoing IBBR using biologic or synthetic meshes and provided outcome data on complications. The primary outcome was overall complication rate; secondary outcomes were implant loss, capsular contracture, infection, seroma, and necrosis. Univariate and multivariate random-effects meta-analyzes were conducted. Multivariate models adjusted for mesh type, implant placement (subpectoral vs. prepectoral), and radiotherapy timing (pre- vs. postoperative). RESULTS: Fifty-one studies were included. The pooled complication rate was 33% (95% CI: 25-41%, p<0.001) for biologic mesh and 30% (95% CI: 13-56%, p=0.347) for synthetic mesh, with no significant difference. Subpectoral placement was associated with significantly higher odds of implant loss (OR = 2.32, 95% CI: 1.24-4.33, p=0.0086) and capsular contracture (OR = 2.91, 95% CI: 1.22-6.95, p=0.0165) compared to prepectoral placement. Preoperative radiotherapy was linked to increased implant loss (OR 1.89, 95% CI 1.21-2.94; p=0.0051). Mesh type did not significantly affect the rates of capsular contracture, implant loss, seroma, or necrosis. CONCLUSION: Biologic and synthetic meshes show comparable clinical outcomes in irradiated IBBR. Implant placement and radiotherapy timing are predictive of complications and support a tailored approach to mesh selection based on clinical and economic considerations.

来源:J Plast Reconstr Aesthet Surg,查看原文。版权归原作者所有。

引用

  1. Fedorcsak DL, Doleviczenyi L, Frivaldszky L, et al. Biologic versus synthetic meshes in irradiated implant-based breast reconstruction: A systematic review and meta-analysis. J Plast Reconstr Aesthet Surg. 2026. PMID: 42456528. doi:10.1016/j.bjps.2026.06.032

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。